BU
IDXX icon

BBVA USA’s Idexx Laboratories IDXX Stock Holding History

BBVA USA’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.39M Sell
2,232
-640
-22% -$430K 0.08% 222
2021
Q2 		$1.81M Buy
+2,872
New +$1.59M 0.1% 198

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BBVA USA's IDXX Position: Q3 2021 in Review

BBVA USA reduced its Idexx Laboratories (IDXX) stake by 22% in Q3 2021, selling an estimated $430K and leaving 2,232 shares worth $1.39M. The position accounts for 0.08% of the portfolio, ranked #222.

BBVA USA first reported a position in IDXX in Q2 2021 and has held it in 2 quarters since. The position peaked at $1.81M in Q2 2021. 1,058 funds tracked by Wall St. Rank hold IDXX as of Q3 2021.

  • BBVA USA held 2,232 shares of Idexx Laboratories worth $1.39M as of Q3 2021.
  • BBVA USA sold 640 Idexx Laboratories shares in Q3 2021, an estimated $430K.
  • Idexx Laboratories made up 0.08% of BBVA USA's portfolio in Q3 2021, its #222 holding.
  • BBVA USA first reported a position in Idexx Laboratories in Q2 2021 and has held it in 2 quarters since.
  • BBVA USA's Idexx Laboratories position peaked at $1.81M in Q2 2021.
  • 1,058 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.